The only outcome measure is 100% recovery! These 'experts' don't know what the fuck they are talking about! I consider the Fugl-Meyer Assessment completely and totally worthless. NOTHING in that testing gets you recovered!
Using Fugl-Meyer for anything in stroke is the height of stupidity, nothing objective in it, so nothing is repeatable.
The only goal in stroke is 100% recovery; so that's what you measure you blithering idiots! Your degrees don't mean you have common sense!
Send me hate mail on this: oc1dean@gmail.com. I'll print your complete statement with your name and my response in my blog. Or are you afraid to engage with my stroke-addled mind? Your patients need an explanation of why you don't know about the only goal in stroke and the measurements needed to get there!
Chronic Stroke Outcome Measures for Motor Function Intervention Trials
Expert Panel Recommendations
Cheryl Bushnell, MD, MHS; Janet Prvu Bettger, ScD; Kevin M. Cockroft, MD, MSc;
Steven C. Cramer, MD, MMSc; Maria Orlando Edelen, PhD; Daniel Hanley, MD;
Irene L. Katzan, MD, MS; Soeren Mattke, MD, DSc; Dawn M. Nilsen, EdD, OTR/L;
Tepring Piquado, PhD; Elizabeth R. Skidmore, PhD, OTR/L; Kay Wing, PT, DPT, NCS, GCS;
Gayane Yenokyan, MD, PhD, MHS, MPH, MPP
Background
About half of survivors with stroke experience severe and significant long-term disability. The purpose of
this article is to review the state of the science and to make recommendations for measuring patient-centric outcomes in
interventions for motor improvement in the chronic stroke phase.
Methods and
Results
A 9-member expert panel reviewed evidence to identify measures of upper and lower extremity
function used to date as outcomes in trials with patients who experienced a stroke ≥6 months before assessment. Outcome
measures were screened using StrokEDGE consensus panel recommendations, and evaluated for availability of a published
minimal clinically important difference. Measures meeting these criteria were further evaluated with regard to their level of
measurement, psychometric properties, and ability of minimal clinically important difference to capture gains associated
with improved function and clinical relevance to patients, to arrive at recommendations. A systematic literature review
yielded 115 clinical trials of upper and lower extremity function in chronic stroke that used a total of 34 outcome measures.
Seven of these had published minimal clinically important differences and were recommended or highly recommended
by StrokEDGE. Those are the Fugl-Meyer Upper Extremity and Lower Extremity scales, Wolf Motor Function Test,
Action Research Arm Test, Ten-Meter and Six-Minute Walk Tests, and the Stroke Impact Scale. All had evidence for their
psychometric performance, although the strength of evidence for validity varied, especially in populations with chronic
stroke Fugl-Meyer Upper and Lower Extremity scales showing the strongest evidence for validity.
Conclusions
The panel recommends that the Fugl-Meyer Upper and Lower Extremity scales be used as primary
outcomes in intervention trials targeting motor function in populations with chronic stroke. The other 6 measures
are recommended as secondary outcomes. (Circ Cardiovasc Qual Outcomes. 2015;8:S163-S169. DOI: 10.1161/
CIRCOUTCOMES.115.002098.)
No comments:
Post a Comment